Jeffrey R. Millman, PhD was recently interviewed for an article in Nature about scalable manufacturing of stem cell products for diabetes cell replacement therapy. In creating induced pluripotent stem (iPS) cells researchers take a person’s skin, blood or other cells, reprogram them into iPS cells, and then use those to grow liver cells, pancreatic β […]
Millman interview in Nature
![Jeffrey R. Millman, PhD](https://endocrinology.wustl.edu/files/2021/10/millman-news-2021-350x233.jpg)